Clinical observation of the add-substract liujunzi decoction on alleviating adverse reaction and enhancing immunity during postoperative chemotherapy for gastric cancer
-
摘要: 目的 观察中药六君子汤加减治疗胃癌术后化疗不良反应临床疗效以及对免疫功能的影响.方法 将64例住院患者分为实验组和对照组,每组32名,实验组进行六君子汤加减联合OLF方案化疗,对照组仅予OLF方案化疗,21天为1个疗程,2个周期后评价疗效,比较2组的不良反应、患者生活质量、免疫功能.结果 对照组出现恶心呕吐、食欲下降、骨髓抑制程度的不良反应均较实验组严重(P＜0.05).对照组化疗后的生活质量评分较前下降明显;2组治疗2个周期后,实验组的生活质量优于对照组(P＜0.05).对于免疫功能,化疗治疗后,对照组患者的CD3+、CD4+、CD8+、CD4 +/CD8+、NK细胞活性均低于化疗前的水平;治疗2个周期后,实验组患者各项免疫功能指标显著优于对照组(P＜0.05).结论 六君子汤治疗胃癌术后化疗患者,可减轻不良反应,提高患者免疫力,改善患者生活质量.Abstract: Objective To observe the clinical effects of the add-substract liujunzi decoction on alleviating adverse reaction and improving immunity system during the postoperative chemotherapy for gastric cancer.Methods The 64 hospitalized patients were randomly divided into experiment group and control group,32 cases in each group.Both groups were given OLF regimen chemotherapy and the experiment group was given the extra add-substract liujunzi decoction.Twenty one days were considered as a treatment cycle.After two cycles,the curative effect was evaluated.The adverse reactions,quality of life and the immune function were compared.Results Compared with the experiment group,the control group showed more serious nausea and vomiting,the loss of appetite and bone marrow inhibition degree (P ＜ 0.05).The score of life quality in control group decreased significantly after chemotherapy.After two cycles,the life quality of the experiment group was significantly better than the control group (P ＜0.05).After the chemotherapy,the CD3 +,CD4 +,CD8 +,CD4 +/CDs + and NK cell activity of control group were significantly lower than those before treatment.After two cycles,all immune function indexes of the experimental group were better than those of the control group (P ＜ 0.05).Conclusion The add-substract liujunzi decoction for the postoperative gastric cancer patients can reduce the adverse reaction,improve the immune function and improve the quality of life.
-
-
期刊类型引用(13)
1. 刘满菊，王小稳，李园园，邰亚辉. C-反应蛋白和铁蛋白检测在儿童难治性支原体肺炎早期诊断及治疗中的意义. 上海医药. 2023(09): 45-47 . 
百度学术
2. 杨欣，李勤云. 纤维支气管镜肺泡灌洗联合阿奇霉素、甲泼尼龙治疗难治性支原体肺炎患儿的效果. 河南医学研究. 2021(07): 1231-1233 . 百度学术
3. 张勇，杨志云. 小儿重症肺炎支原体肺炎应用不同剂量甲泼尼龙辅助治疗对患儿肺功能的影响. 中外医疗. 2021(03): 67-69 . 百度学术
4. 孙京革. 甲泼尼龙琥珀酸钠治疗小儿重症支原体肺炎的最佳剂量探究. 中国现代药物应用. 2020(02): 134-136 . 百度学术
5. 焦海燕. 小儿难治性支原体肺炎急性期应用糖皮质激素小剂量给药的临床研究. 医药论坛杂志. 2020(01): 117-119 . 百度学术
6. 马斌，黄娜，仲凤仙. 甲泼尼龙联合阿奇霉素治疗难治性支原体肺炎患儿疗效观察. 内科. 2020(01): 75-77 . 百度学术
7. 陈彦君，张光华，欧阳洪桥. 阿奇霉素联合甲泼尼龙治疗30例小儿难治性支原体肺炎的效果及安全性探讨. 上海医药. 2020(11): 24-27 . 百度学术
8. 周宏媛，马莉娟，杨君，王娴娴，吴令琴，单子鸿，王舒颖，周瑞. 两种剂量糖皮质激素在儿童难治性支原体肺炎中的疗效. 蚌埠医学院学报. 2020(07): 891-894 . 百度学术
9. 张中兴. 人干扰素诱导蛋白10及趋化因子受体3在儿童难治性支原体肺炎患者中的表达及意义. 中国医学工程. 2019(08): 24-27 . 百度学术
10. 苏国德，丁丽丽，张振坤，刘晓鸣. 不同剂量甲泼尼龙治疗儿童难治性肺炎支原体肺炎的临床效果及其对患儿免疫功能和预后的影响. 中国医学前沿杂志(电子版). 2019(10): 71-74 . 百度学术
11. 王小勇. 儿童难治性支原体肺炎激素治疗效果评价及临床特征分析. 首都食品与医药. 2019(23): 61 . 百度学术
12. 邹国新，张慧丽，朱少合，姚家瑜. 阿奇霉素联合丙种球蛋白治疗难治性支原体肺炎临床效果评价. 中国现代医生. 2019(33): 63-66 . 百度学术
13. 王海燕. 小剂量糖皮质激素辅助治疗小儿肺炎支原体肺炎的临床疗效观察. 临床医药文献电子杂志. 2018(69): 140 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 275
- HTML全文浏览量: 64
- PDF下载量: 6
- 被引次数: 13
下载:
苏公网安备 32100302010246号
